148 related articles for article (PubMed ID: 19270462)
1. Psychomotor changes in major depressive disorder during sertraline treatment.
Schrijvers D; Maas YJ; Pier MP; Madani Y; Hulstijn W; Sabbe BG
Neuropsychobiology; 2009; 59(1):34-42. PubMed ID: 19270462
[TBL] [Abstract][Full Text] [Related]
2. Effects of sertraline on depressive symptoms and attentional and executive functions in major depression.
Constant EL; Adam S; Gillain B; Seron X; Bruyer R; Seghers A
Depress Anxiety; 2005; 21(2):78-89. PubMed ID: 15884090
[TBL] [Abstract][Full Text] [Related]
3. Spotlight on sertraline in the management of major depressive disorder in elderly patients.
Muijsers RB; Plosker GL; Noble S
CNS Drugs; 2002; 16(11):789-94. PubMed ID: 12383038
[TBL] [Abstract][Full Text] [Related]
4. New generation antidepressants for depression in children and adolescents: a network meta-analysis.
Hetrick SE; McKenzie JE; Bailey AP; Sharma V; Moller CI; Badcock PB; Cox GR; Merry SN; Meader N
Cochrane Database Syst Rev; 2021 May; 5(5):CD013674. PubMed ID: 34029378
[TBL] [Abstract][Full Text] [Related]
5. Efficacy of sertraline in the treatment of children and adolescents with major depressive disorder.
Spielmans GI
JAMA; 2004 Jan; 291(1):41. PubMed ID: 14709570
[No Abstract] [Full Text] [Related]
6. Efficacy of sertraline in the treatment of children and adolescents with major depressive disorder.
Solyom AE
JAMA; 2004 Jan; 291(1):41-2; author reply 42. PubMed ID: 14709569
[No Abstract] [Full Text] [Related]
7. Efficacy of sertraline in the treatment of children and adolescents with major depressive disorder.
Price D
JAMA; 2004 Jan; 291(1):40-1; author reply 42. PubMed ID: 14709568
[No Abstract] [Full Text] [Related]
8. Efficacy of sertraline in the treatment of children and adolescents with major depressive disorder.
Mathews M; Mathews M; Mathews J
JAMA; 2004 Jan; 291(1):40; author reply 42. PubMed ID: 14709567
[No Abstract] [Full Text] [Related]
9. Sertraline and depression in children.
Garland EJ
JAMA; 2004 Apr; 291(13):1561; author reply 1561-2. PubMed ID: 15069038
[No Abstract] [Full Text] [Related]
10. Change in cognitive functioning in depressed older adults following treatment with sertraline or nortriptyline.
Culang-Reinlieb ME; Sneed JR; Keilp JG; Roose SP
Int J Geriatr Psychiatry; 2012 Aug; 27(8):777-84. PubMed ID: 21919060
[TBL] [Abstract][Full Text] [Related]
11. Selective serotonin reuptake inhibitor treatment of major depressive disorder in children and adolescents.
Newcorn JH
Curr Psychiatry Rep; 2004 Apr; 6(2):85-7. PubMed ID: 15038909
[No Abstract] [Full Text] [Related]
12. Vortioxetine for major depressive disorder: An indirect comparison with duloxetine, escitalopram, levomilnacipran, sertraline, venlafaxine, and vilazodone, using number needed to treat, number needed to harm, and likelihood to be helped or harmed.
Citrome L
J Affect Disord; 2016 May; 196():225-33. PubMed ID: 26938965
[TBL] [Abstract][Full Text] [Related]
13. Comparative efficacy of sertraline vs. fluoxetine in patients age 70 or over with major depression.
Finkel SI; Richter EM; Clary CM; Batzar E
Am J Geriatr Psychiatry; 1999; 7(3):221-7. PubMed ID: 10438693
[TBL] [Abstract][Full Text] [Related]
14. Sertraline and cognitive behavioral therapy for depressed alcoholics: results of a placebo-controlled trial.
Moak DH; Anton RF; Latham PK; Voronin KE; Waid RL; Durazo-Arvizu R
J Clin Psychopharmacol; 2003 Dec; 23(6):553-62. PubMed ID: 14624185
[TBL] [Abstract][Full Text] [Related]
15. Heart rate variability is a trait marker of major depressive disorder: evidence from the sertraline vs. electric current therapy to treat depression clinical study.
Brunoni AR; Kemp AH; Dantas EM; Goulart AC; Nunes MA; Boggio PS; Mill JG; Lotufo PA; Fregni F; Benseñor IM
Int J Neuropsychopharmacol; 2013 Oct; 16(9):1937-49. PubMed ID: 23759172
[TBL] [Abstract][Full Text] [Related]
16. Antidepressant treatment strategy with an early onset of action improves the clinical outcome in patients with major depressive disorder and high anxiety: a multicenter and 6-week follow-up study.
Liao XM; Su YA; Wang Y; Yu X; Si TM
Chin Med J (Engl); 2020 Mar; 133(6):726-728. PubMed ID: 32097208
[No Abstract] [Full Text] [Related]
17. Efficacy of sertraline in the treatment of children and adolescents with major depressive disorder: two randomized controlled trials.
Wagner KD; Ambrosini P; Rynn M; Wohlberg C; Yang R; Greenbaum MS; Childress A; Donnelly C; Deas D;
JAMA; 2003 Aug; 290(8):1033-41. PubMed ID: 12941675
[TBL] [Abstract][Full Text] [Related]
18. Effect of Sertraline on Depressive Symptoms in Patients With Chronic Kidney Disease Without Dialysis Dependence: The CAST Randomized Clinical Trial.
Hedayati SS; Gregg LP; Carmody T; Jain N; Toups M; Rush AJ; Toto RD; Trivedi MH
JAMA; 2017 Nov; 318(19):1876-1890. PubMed ID: 29101402
[TBL] [Abstract][Full Text] [Related]
19. Sertraline: a review of its use in the management of major depressive disorder in elderly patients.
Muijsers RB; Plosker GL; Noble S
Drugs Aging; 2002; 19(5):377-92. PubMed ID: 12093324
[TBL] [Abstract][Full Text] [Related]
20. Response to sertraline is influenced by GNβ3 gene G-350A variant in patients with major depressive disorder.
Firouzabadi D; Firouzabadi N; Kalani K; Zomorrodian K; Tehrani ES
Eur J Clin Pharmacol; 2019 Feb; 75(2):189-194. PubMed ID: 30324302
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]